NJ police used baby DNA to investigate crimes, lawsuit claims
By Corin Faife,
The Verge
| 08. 29. 2022
New Jersey police may have used blood samples taken from babies to investigate crimes, according to public defenders in the state.
According to a lawsuit filed by the New Jersey Office of the Public Defender (OPD), the practice came to light after a case in which New Jersey State Police successfully subpoenaed a testing lab for a blood sample drawn from a child. Police then performed DNA analysis on the blood sample that reportedly linked the child’s father to a crime committed more than 25 years ago.
The suspect then became a client of the OPD, which alerted the office to the techniques used to identify the man. The lawsuit, filed jointly by the OPD and the New Jersey Monitor, now seeks to compel the state of New Jersey to disclose information on the full extent of the practice.
All babies born in the state of New Jersey are required to have a blood sample drawn within 48 hours as part of a mandatory testing program that screens them for 60 different disorders. These samples are processed in a...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
